Researchers at University of California campuses at Davis and San Diego have developed a new, neuroplasticity-promoting drug ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...

Novartis will invest $23bn in US-based manufacturing and research and development (R&D) over the next five years, becoming ...

It is part of a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure.

Pfizer is officially bidding adieu to its sprawling research site in San Diego as it readjusts its local footprint and moves into a new site. | The company is moving its oncology R&D digs in San Diego ...

From stock decline to Hold rating, explore their growth strategy, client focus, and potential gains. Click for my MRVI update.

Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.

Biotech companies create drugs from living organisms, requiring a BLA for FDA approval. Pharma companies develop drugs from chemicals, needing an NDA for FDA approval. Many firms blend biotech and ...

While it is far from recovered, this generalized “Biotech Rout’ have also put the stock of individual attractive company under their real value. If there is one investment sector that does not yield ...